News
CHMP issues negative opinion on conditional marketing authorization for Roche’s gene therapy, Elevidys for Duchenne muscular dystrophy: Basel Monday, July 28, 2025, 15:00 Hrs [I ...
19hOpinion
The Trump FDA tries to kill a therapy that has helped boys with a deadly diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback